| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Glenmark Pharma gains after JV submits IND application for cancer drug ISB 2301 | 2 | capitalmarket.com | ||
| Di | Ichnos Glenmark Innovation Inc.: Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors | 406 | PR Newswire | Ichnos Glenmark Innovation (IGI) Announces IND Submission to U.S. FDA for ISB 2301, a First-in-Class Multispecific Immune Cell Activator Targeting Solid Tumors
ISB 2301 targets three tumor-associated... ► Artikel lesen | |
| 09.11. | Glenmark Pharmaceuticals Ltd gains for third straight session | 3 | capitalmarket.com | ||
| 05.11. | Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr | 3 | Times of India | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 05.11. | Glenmark Pharmaceuticals Q2 Profit Plunges 56.7% To Rs 264 Crore | 2 | The Free Press Journal | ||
| 30.10. | Glenmark opens Allentown distribution hub in US | 3 | Pharmaceutical Technology | ||
| 23.09. | Glenmark Pharma gets EIR for Goa facility from US FDA | 4 | capitalmarket.com | ||
| 22.09. | Glenmark Pharmaceuticals Ltd spurts 0.5%, gains for fifth straight session | 2 | capitalmarket.com | ||
| 21.09. | Pharma Stocks Rally: BSE Healthcare index hits new high, Sun Pharma, Torrent Pharma, Glenmark gain up to 5% | 4 | ZEE Business | ||
| 10.09. | Glenmark, South Piedmont Launch Pharma Training Facility | 4 | Contract Pharma | ||
| 26.08. | Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session | 2 | capitalmarket.com | ||
| 21.08. | Glenmark Pharma's US arm launches Calcium Gluconate injection in various formats | 2 | capitalmarket.com | ||
| 21.08. | Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswing | 2 | Times of India | ||
| 20.08. | Glenmark Pharma gets USFDA nod for Fluticasone Propionate Nasal Spray | 4 | capitalmarket.com | ||
| 03.08. | Glenmark Q1 FY27 slides: 23% revenue growth, innovation pipeline expands | 3 | Investing.com | ||
| 15.07. | Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session | 3 | capitalmarket.com | ||
| 06.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 06.07. | Glenmark Pharma gains as US arm launches generic Olanzapine injection | 2 | capitalmarket.com | ||
| 17.06. | Glenmark Pharma arm launches generic Methylene Blue Injection in US market | 3 | capitalmarket.com | ||
| 11.06. | Glenmark Pharmaceuticals launches Winlevi across key European markets | 2 | capitalmarket.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,914 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 0,901 | 0,00 % | CSPC Pharmaceutical Group Ltd. Announces Rise In Nine Months Bottom Line | ||
| WUXI BIOLOGICS | 5,090 | 0,00 % | Der China-Schatz: Fresenius sichert sich 37 neue Biosimilar-Kandidaten | © Foto: Arne Dedert/dpaFresenius sichert sich über einen Exklusivvertrag mit WuXi Biologics Zugriff auf bis zu 37 neue Biosimilars. Die Pipeline könnte sich mehr als verdoppeln. DZ Bank und Jefferies... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,765 | +4,41 % | FOSUN PHARMA Repurchases 1.807M Shrs on Wed for HKD26.94M | ||
| GEDEON RICHTER | 37,000 | -1,65 % | Richter Agrees to Acquire Mayne Pharma for AUD 604 mln | ||
| DR REDDYS | 13,500 | -1,46 % | Gilead Inks Deals with Dr. Reddy's, Eva Pharma, Ferozsons to Expand Ebola BVD Treatment | ||
| ASPEN PHARMACARE | 9,250 | -1,07 % | ASPEN PHARMACARE HOLDINGS LIMITED - Regulatory Approvals for Aspens Generic Injectable Semaglutide in Brazil and South Africa | ||
| SHANGHAI PHARMACEUTICALS | 1,250 | +1,63 % | Dividendenbekanntmachungen (23.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCE AUTO PARTS INC US00751Y1064 0,25 USD EUR ALPHAMIN RESOURCES CORP MU0456S00006 0,13 CAD 0,0827 EUR AMERICAN FINANCIAL GROUP... ► Artikel lesen | |
| LUYE PHARMA | 0,173 | -1,14 % | LUYE PHARMA Depression Treatment Drug Approved for US Clinical Trials | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,085 | -2,30 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - NEW INDICATION OF XUANZHU BIOPHARM'S BIREOCICLIB INCLUDED IN THE 2026 NRDL | ||
| HANSOH PHARMACEUTICAL | 3,704 | 0,00 % | HANSOH PHARMA Enters Cooperative Development Agreement with Angxin Bio Involving AI Platform License Worth Up to RMB300M | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,510 | -2,86 % | CHINARES PHARMA (03320): INSIDE INFORMATION REGISTRATION OF DEBT FINANCING INSTRUMENTS BY THE NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS ... | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,920 | +1,10 % | Dividendenbekanntmachungen (15.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD 0,5648 EUR ABBOTT LABORATORIES CDR CA0028221046 0,1096 CAD 0,069 EUR ABBVIE INC US00287Y1091 1... ► Artikel lesen | |
| KALBE FARMA | 0,031 | 0,00 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| BAYER | 55,94 | -0,36 % | Singulus-Aktie +1.500 % dank Elon Musk! Was machen Almonty und Bayer? | Mehr als 1.500 % konnte die Singulus-Aktie im laufenden Jahr zulegen. Ein ganz wesentlicher Grund, warum der Maschinenbauer vom Pleitekandidaten zum Überflieger geworden ist, ist Elon Musk. Der erste... ► Artikel lesen |